HomeAdalimumab BwwdAdalimumab Bwwd + Methotrexate

Does Adalimumab Bwwd Interact with Methotrexate?

Adalimumab Bwwd and Methotrexate have a moderate drug interaction according to U.S. FDA drug labeling data. MTX reduces apparent adalimumab clearance but no dose adjustment needed for either drug. The mechanism involves mtx reduces adalimumab clearance. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This information is based on official FDA drug labeling sourced from OpenFDA and the NIH National Library of Medicine.

Severity
Moderate
Adalimumab Bwwd Class
Tumor Necrosis Factor Blocker
Methotrexate Class
Folate Analog Metabolic Inhibitor
Management
Monitor for effects
Data Source
U.S. FDA via OpenFDA

How This Interaction Works

The interaction between Adalimumab Bwwd and Methotrexate occurs because mtx reduces adalimumab clearance. Clinically, this means mtx reduces apparent adalimumab clearance but no dose adjustment needed for either drug. This is classified as a moderate interaction. While it may not require stopping either medication, your healthcare provider should be aware you are taking both so they can monitor for potential effects and adjust treatment if necessary.

What To Tell Your Doctor or Pharmacist

If you are taking Adalimumab Bwwd and your doctor is considering prescribing Methotrexate (or vice versa), make sure to:

  • Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
  • Ask whether the benefits of combining these medications outweigh the risks for your specific situation
  • Ask what symptoms to watch for that would indicate the interaction is causing problems
  • Ask whether any dosage adjustments are needed
  • Never stop or change either medication without first consulting your healthcare provider
💊 Adalimumab Bwwd(Hadlima)+💊 Methotrexate(Otrexup)

Severity & Interaction Details

🟡
moderate
Be aware — moderate interaction
Documented interaction with manageable risk. May require dose adjustment or monitoring.
Severity scale
MinorContra
On record
Yes
Drug A class
Tumor Necrosis Factor Blocker
Drug B class
Folate Analog Metabolic Inhibitor
Source
NLP:adalimumab-bwwd

What this means in plain English

MTX reduces apparent adalimumab clearance but no dose adjustment needed for either drug.

About Adalimumab Bwwd and Methotrexate

Adalimumab Bwwd is a Tumor Necrosis Factor Blocker, while Methotrexate is a Folate Analog Metabolic Inhibitor. You may recognize them by the brand names Hadlima and Otrexup. Adalimumab Bwwd is given by injection under the skin, whereas Methotrexate is given by intramuscular injection. Both Adalimumab Bwwd and Methotrexate carry an FDA boxed warning — the agency's most serious safety designation.

What the FDA label says

"MTX reduces adalimumab clearance"

📖 Source: NLP:adalimumab-bwwd

Share this result:

WhatsAppText / SMSEmail
Also share on:XFacebook
Add more drugs
Check Adalimumab Bwwd and Methotrexate against your full medication list

Most patients take more than two medications. CDI checks every pair across up to 20 drugs simultaneously — including OTCs and common supplements.

Add more drugs →
Data integrity: Every interaction shown is extracted directly from official U.S. FDA drug labeling via openFDA and the U.S. National Library of Medicine (NIH) — no interactions are invented, inferred, or manually edited. Maintained by CheckDrugInteractions.com. See our methodology or report a correction at support@checkdruginteractions.com.

Data sourced from U.S. FDA drug labeling via openFDA and the NIH National Library of Medicine, supplemented with a small number of well-established interactions from curated clinical references. For informational purposes only. Always consult your pharmacist or physician.